Ambulatory Blood Pressure Monitoring: Five Decades of More Light and Less Shadows

Nenhuma Miniatura disponível
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
ARQUIVOS BRASILEIROS CARDIOLOGIA
Autores
NOBRE, Fernando
Citação
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, v.106, n.6, p.528-537, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Casual blood pressure measurements have been extensively questioned over the last five decades. A significant percentage of patients have different blood pressure readings when examined in the office or outside it. For this reason, a change in the paradigm of the best manner to assess blood pressure has been observed. The method that has been most widely used is the Ambulatory Blood Pressure Monitoring - ABPM. The method allows recording blood pressure measures in 24 hours and evaluating various parameters such as mean BP, pressure loads, areas under the curve, variations between daytime and nighttime, pulse pressure variability etc. Blood pressure measurements obtained by ABPM are better correlated, for example, with the risks of hypertension. The main indications for ABPM are: suspected white coat hypertension and masked hypertension, evaluation of the efficacy of the antihypertensive therapy in 24 hours, and evaluation of symptoms. There is increasing evidence that the use of ABPM has contributed to the assessment of blood pressure behaviors, establishment of diagnoses, prognosis and the efficacy of antihypertensive therapy. There is no doubt that the study of 24-hour blood pressure behavior and its variations by ABPM has brought more light and less darkness to the field, which justifies the title of this review.
Palavras-chave
Blood Pressure Monitoring, Ambulatory / trends, Hypertension, White Coat Hypertension, Medication Therapy Management
Referências
  1. Alessi Alexandre, 2005, Arq. Bras. Cardiol., V85, P1, DOI 10.1590/S0066-782X2005002100001
  2. Amodeo C, 1997, Arq Bras Cardiol, V69, P359
  3. Andrade J.P., 2011, Arq. Bras. Cardiol., V97, P01, DOI 10.1590/S0066-782X2011001600001
  4. [Anonymous], 1993, Arq Bras Cardiol, V60, P129
  5. [Anonymous], 2019, HYP AD DIAGN MAN
  6. [Anonymous], 1896, GAZ MED ITAL TORINO
  7. AYMAN DAVID, 1940, AMER JOUR MED SCI, V200, P465, DOI 10.1097/00000441-194010000-00005
  8. Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262
  9. Bobrie G, 2008, J HYPERTENS, V26, P1715, DOI 10.1097/HJH.0b013e3282fbcedf
  10. Boggia J, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0470-8
  11. Bombelli M, 2013, CURR HYPERTENS REP, V15, P238, DOI 10.1007/s11906-013-0348-1
  12. Brotman DJ, 2008, AM J HYPERTENS, V21, P92, DOI 10.1038/ajh.2007.7
  13. Campbell NRC, 2012, CAN MED ASSOC J, V184, P633, DOI 10.1503/cmaj.110501
  14. Centers for Medicare & Medicaid Services. (CMS), 2001, MED COV POL DEC ABPM
  15. Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273
  16. Cloutier L, 2015, CAN J CARDIOL, V31, P620, DOI 10.1016/j.cjca.2015.02.014
  17. Conen D, 2008, J HYPERTENS, V26, P1290, DOI 10.1097/HJH.0b013e3282f97854
  18. Cuspidi C, 2015, AM J HYPERTENS, V28, P806, DOI 10.1093/ajh/hpu231
  19. Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a
  20. Dolan E, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0649-x
  21. Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727
  22. Fan HQ, 2010, J HYPERTENS, V28, P2036, DOI 10.1097/HJH.0b013e32833b49fe
  23. Flynn JT, 2014, HYPERTENSION, V63, P1116, DOI 10.1161/HYP.0000000000000007
  24. Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354
  25. Franklin SS, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0474-4
  26. Franklin SS, 2013, HYPERTENSION, V62, P982, DOI 10.1161/HYPERTENSIONAHA.113.01275
  27. Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653
  28. Gomes M A, 2000, Arq Bras Cardiol, V74, P314
  29. GOMES MA, 1998, ARQ BRAS CARDIOL, V71, P66
  30. Hansen TW, 2010, HYPERTENSION, V55, pE27, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]
  31. Hansen TW, 2007, J HYPERTENS, V25, P1554, DOI 10.1097/HJH.0b013e3281c49da5
  32. Hara A, 2012, HYPERTENSION, V59, P22, DOI 10.1161/HYPERTENSIONAHA.111.174938
  33. Head GA, 2011, AUST FAM PHYSICIAN, V40, P877
  34. Hermida RC, 2013, CHRONOBIOL INT, V30, P355, DOI 10.3109/07420528.2013.750490
  35. HINMAN AT, 1962, AM HEART J, V63, P663, DOI 10.1016/0002-8703(62)90011-X
  36. KAIN HK, 1964, CIRCULATION, V30, P882, DOI 10.1161/01.CIR.30.6.882
  37. Kikuya M, 2005, HYPERTENSION, V45, P240, DOI 10.1161/01.HYP.0000152079.04553.2c
  38. Lovibond K, 2011, LANCET, V378, P1218
  39. MANCIA G, 1983, LANCET, V2, P695
  40. Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708
  41. Manios ED, 2008, AM J HYPERTENS, V21, P153, DOI 10.1038/ajh.2007.43
  42. Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a
  43. Mena LJ, 2014, AM J HYPERTENS, V27, P46, DOI 10.1093/ajh/hpt142
  44. Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879
  45. Nobre F, 2005, BLOOD PRESS MONIT, V10, P263, DOI 10.1097/01.mbp.0000180669.38161.6e
  46. Nobre Fernando, 2003, Arq. Bras. Cardiol., V81, P428, DOI 10.1590/S0066-782X2003001200012
  47. O'Brien E, 2010, BLOOD PRESS MONIT, V15, P171, DOI 10.1097/MBP.0b013e32833b7c0c
  48. O'Brien E, 2013, HYPERTENSION, V62, P988, DOI 10.1161/HYPERTENSIONAHA.113.02148
  49. O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964
  50. O'Brien E, 2010, BLOOD PRESS MONIT, V15, P23, DOI 10.1097/MBP.0b013e3283360e98
  51. OBRIEN E, 1988, LANCET, V2, P397
  52. Omboni S, 2015, BLOOD PRESS MONIT, V20, P241, DOI 10.1097/MBP.0000000000000135
  53. Ortega KC, 2008, HYPERTENSION, V52, pE10, DOI 10.1161/HYPERTENSIONAHA.108.115394
  54. Ortega Katia Coelho, 2005, Arq. Bras. Cardiol., V85, P208, DOI 10.1590/S0066-782X2005001600011
  55. Parati G, 2005, J HYPERTENS, V23, pS19, DOI 10.1097/01.hjh.0000165624.79933.d3
  56. Parati G, 2014, J HYPERTENS, V32, P1359, DOI 10.1097/HJH.0000000000000221
  57. Peacock J, 2014, J HUM HYPERTENS, V28, P521, DOI 10.1038/jhh.2014.9
  58. PERLOFF D, 1983, JAMA-J AM MED ASSOC, V249, P2792, DOI 10.1001/jama.249.20.2792
  59. Pierdomenico SD, 2011, AM J HYPERTENS, V24, P52, DOI 10.1038/ajh.2010.203
  60. Pierin AM, 2002, J HYPERTENS, V20, pS975
  61. Schrader J, 2000, J HUM HYPERTENS, V14, P435, DOI 10.1038/sj.jhh.1001052
  62. Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B
  63. Segre Carlos A, 2003, Arq Bras Cardiol, V80, P117
  64. Shimada K, 2012, CIRC J, V76, P508, DOI 10.1253/circj.CJ-88-0020
  65. Silva Giovanio Vieira da, 2005, Arq Bras Cardiol, V85, P215
  66. Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065
  67. Turner JR, 2015, AM J MED, V128, P14, DOI 10.1016/j.amjmed.2014.07.021
  68. Verdecchia P, 1998, HYPERTENSION, V32, P983, DOI 10.1161/01.HYP.32.6.983
  69. 2001, ARQ BRAS CARDIOL, V77, P384